UK markets open in 4 hours 50 minutes

Vertex Pharmaceuticals Inc (VX1.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
406.20-3.10 (-0.76%)
At close: 08:08AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
10,185,000
9,869,200
8,930,700
7,574,400
6,205,700
-
Cost of revenue
1,337,900
1,262,200
1,080,300
904,200
736,300
-
Gross profit
8,847,100
8,607,000
7,850,400
6,670,200
5,469,400
-
Operating expenses
Research development
3,209,400
3,162,900
2,540,300
1,937,800
1,829,500
-
Selling general and administrative
1,238,200
1,136,600
944,700
840,100
770,500
-
Total operating expenses
4,447,600
4,299,500
3,485,000
2,777,900
2,600,000
-
Operating income or loss
4,399,500
4,307,500
4,365,400
3,892,300
2,869,400
-
Interest expense
43,100
44,100
54,800
61,500
58,200
-
Total other income/expenses net
-262,300
-498,300
-222,800
-1,105,300
283,500
-
Income before tax
4,767,400
4,379,800
4,232,400
2,730,400
3,116,900
-
Income tax expense
748,000
760,200
910,400
388,300
405,200
-
Income from continuing operations
4,019,400
3,619,600
3,322,000
2,342,100
2,711,700
-
Net income
4,019,400
3,619,600
3,322,000
2,342,100
2,711,700
-
Net income available to common shareholders
4,019,400
3,619,600
3,322,000
2,342,100
2,711,700
-
Basic EPS
13.48
-
12.97
9.09
10.44
4.58
Diluted EPS
13.32
-
12.82
9.01
10.29
4.51
Basic average shares
257,525
-
256,100
257,700
259,841
256,728
Diluted average shares
260,375
-
259,100
259,900
263,396
260,673